Advagraf 5mg Tbl (Box/30Tbl)

Content:  Tacrolimus Indication: For the prophylaxis of transplant rejection in adult kidney or liver allograft recipients, and treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients. Dosage: Advagraf is a once-a-day oral formulation of tacrolimus. Tacrolimus monohydrate (Advagraf) therapy requires careful monitoring by adequately qualified and equipped personnel. This medicinal product should only be prescribed, and changes in immunosuppressive therapy initiated, by physicians experienced in immunosuppressive therapy and the management of transplant patients.Inadvertent, unintentional or unsupervised switching of immediate- or prolonged-release formulations of tacrolimus is unsafe. This can lead to graft rejection or increased incidence of side effects, including under- or over-immunosuppression, due to clinically relevant differences in systemic exposure to tacrolimus. Patients should be maintained on a single formula